During the past decade, Summa Health System conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 28 clinical trials were completed, i.e. on average, 96.6% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summa Health System" #1 sponsor was "Summa Health System" with 11 trials, followed by "Gilead Sciences" with 6 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Juventas Therapeutics, Inc." with 4 trials sponsored and "Kent State University" with 4 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summa Health System" #1 collaborator was "Summa Health System" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Augusta University" with 1 trials as a collaborator and "BTG International Inc." with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Summa Health System" are "HIV Infections" (10 trials), "Heart Failure" (6 trials), "HIV" (4 trials), "Coronary Artery Disease" (3 trials) and "Stroke" (3 trials). Many other conditions were trialed in "Summa Health System" in a lesser frequency.

Most popular intervention types in "Summa Health System" are "Drug" (49 trials), "Device" (14 trials), "Biological" (7 trials), "Other" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "ATV" (2 trials), "Abacavir sulfate" (2 trials), "E/C/F/TAF" (2 trials) and "E/C/F/TDF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Summa Health System" are 81 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Summa Health System". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 54 completed trials in Summa Health System, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Summa Health System, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".